Vitamin D Enhances Interferon-beta Response in Multiple Sclerosis

被引：0
|
作者：
Feng, Xuan [3 ]
Wang, Zhe [1 ]
Causevic, Suad [2 ]
Howlett-Prieto, Quentin [3 ]
Rubin, Danielle [3 ]
Einhorn, Nathan [3 ]
Reder, Anthony [3 ]
机构：
[1] Dalian Med Univ, Affiliated Hosp 1, Dept Neurol, Neurol, Dalian, Peoples R China
[2] Univ Chicago, Chicago, IL 60637 USA
[3] Univ Chicago, Neurol, Chicago, IL 60637 USA
来源：
NEUROLOGY | 2016年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P3.103
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Pharmacogenomics biomarkers in multiple sclerosis: Transcriptional profiling of the B cell response to interferon-beta
    Khsheibun, Rana
    Paperna, Tamar
    Avidan, Nili
    Volkovitz, Anat
    Ginsburg, Elizabeta
    Miller, Ariel
    JOURNAL OF NEUROIMMUNOLOGY, 2012, 253 (1-2) : 21 - 21
  • [42] IL28B polymorphisms are not associated with the response to interferon-beta in multiple sclerosis
    Malhotra, S.
    Morcillo-Suarez, C.
    Brassat, D.
    Goertsches, R.
    Lechner-Scott, J.
    Urcelay, E.
    Fernandez, O.
    Drulovic, J.
    Garcia-Merino, A.
    Boneschi, F. Martinelli
    Chan, A.
    Vandenbroeck, K.
    Navarro, A.
    Bustamante, M. F.
    Rio, J.
    Akkad, D. A.
    Giacalone, G.
    Sanchez, A. J.
    Leyva, L.
    Alvarez-Lafuente, R.
    Zettl, U. K.
    Oksenberg, J.
    Montalban, X.
    Comabella, M.
    JOURNAL OF NEUROIMMUNOLOGY, 2011, 239 (1-2) : 101 - 104
  • [43] Natural killer cell phenotype and clinical response to interferon-beta therapy in multiple sclerosis
    Martinez-Rodriguez, J. E.
    Lopez-Botet, M.
    Munteis, E.
    Rio, J.
    Roquer, J.
    Montalban, X.
    Comabella, M.
    CLINICAL IMMUNOLOGY, 2011, 141 (03) : 348 - 356
  • [44] Interferon-beta in multiple sclerosis: ten years' experience in a multiple sclerosis specialist centre
    Khalil, M.
    Zehrer, V.
    Egg, R.
    Lutterotti, A.
    Ehling, R.
    Gneiss, C.
    Mayringer, I.
    Kuenz, B.
    Reindl, M.
    Deisenhammer, F.
    Berger, T.
    MULTIPLE SCLEROSIS, 2006, 12 : S195 - S195
  • [45] Arthritis and bursitis in multiple sclerosis patients treated with interferon-beta
    Strueby, L
    Nair, B
    Kirk, A
    Taylor-Gjevre, RM
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2005, 34 (06) : 485 - 488
  • [46] Predictive markers to interferon-beta therapy in multiple sclerosis patients
    Charbit, H.
    Geyshis, B.
    Karussis, D.
    Petrou, P.
    Smith, Y.
    Vaknin-Dembinsky, A.
    Lavon, I.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S232 - S233
  • [47] Rare Side effects of Therapy with Interferon-beta in Multiple Sclerosis
    Hohlfeld, I
    Simon, J. C.
    Wetzig, T.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2011, 9 : 205 - 205
  • [48] Combination therapy with interferon-beta and glatiramer acetate in multiple sclerosis
    Ytterberg, C.
    Johansson, S.
    Anderson, M.
    Olsson, D.
    Link, H.
    Holmqvist, L. W.
    von Koch, L.
    ACTA NEUROLOGICA SCANDINAVICA, 2007, 116 (02): : 96 - 99
  • [49] Bioavailability of Interferon-beta in patients with multiple sclerosis - fishing for the surrogate
    Kieseier, B. C.
    Hartung, H. -P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 (03) : 344 - 345
  • [50] Mediastinal sarcoidosis in a patient receiving interferon-beta for multiple sclerosis
    O'Reilly, S
    White, A
    Florian, A
    CHEST, 2005, 128 (04) : 450S - 451S
12345